Please use this identifier to cite or link to this item: http://localhost:8081/xmlui/handle/123456789/2154
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnuradha-
dc.date.accessioned2014-09-26T13:12:27Z-
dc.date.available2014-09-26T13:12:27Z-
dc.date.issued2012-
dc.identifierM.Techen_US
dc.identifier.urihttp://hdl.handle.net/123456789/2154-
dc.guideSharma, Anuj-
dc.description.abstractMalaria is one of the serious hurdles to public health with about one million deaths annually. Present chemotherapies are inadequate because of the genesis and emergence of new drug resistance strains. So there is a urgent need to recognize new inhibitors against known or novel targets. Herein we are presenting docking studies of bioactive natural plant products against Pf DHFR. For this purpose we have built a library of 205 active molecules of plant origin having some folklore history as being used as antimalarial. Three docking engines AutoDock 4.2, MVD 5.0 (Molegro Virtual Docker) and iGEMDOCK 2.1 were used for Screening. AutoDock and iGEMDOCK runs resulted in the energy scores from -4.6 to -12.07 Kcal/mol and -63 to =156.2 kcal/mol respectively. Our analysis shows Ochrolifuanine and Chrobisiamine as most promising hit with K; in nanomolar range. We also focused on the common structure features of ligand and the residues of protein which remain almost conserved throughout the analysis. We hoped this work would aid in antimalarial combat strategies and can serve to provide new therapeuticals in a rapid manneren_US
dc.language.isoenen_US
dc.subjectCHEMISTRYen_US
dc.subjectSILICO DOCKING STUDIESen_US
dc.subjectBIOACTIVE NATURAL PRODUCTSen_US
dc.subjectPUTATIVE Pf-DHFR ANTAGONISTSen_US
dc.titleIN SILICO DOCKING STUDIES OF BIOACTIVE NATURAL PRODUCTS AS PUTATIVE Pf-DHFR ANTAGONISTSen_US
dc.typeM.Tech Dessertationen_US
dc.accession.numberG21807en_US
Appears in Collections:MASTERS' THESES (Chemistry)

Files in This Item:
File Description SizeFormat 
CHDG21807.pdf9.72 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.